Biotalys NV (EBR:BTLS)

Belgium flag Belgium · Delayed Price · Currency is EUR
4.450
-0.160 (-3.47%)
Aug 1, 2025, 5:35 PM CET
-3.47%
Market Cap166.74M
Revenue (ttm)n/a
Net Income (ttm)-13.19M
Shares Out37.47M
EPS (ttm)-0.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,115
Average Volume28,211
Open4.590
Previous Close4.610
Day's Range4.420 - 4.600
52-Week Range2.510 - 5.500
Beta0.96
RSI35.96
Earnings DateAug 21, 2025

About Verve Therapeutics

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN... [Read more]

Sector Materials
Founded 2013
Employees 63
Stock Exchange Euronext Brussels
Ticker Symbol BTLS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.